MedPath

N6 Input Processing in Traditional CI Recipients

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: Nucleus 6 Sound Processor
Registration Number
NCT02239263
Lead Sponsor
Cochlear
Brief Summary

The purpose of this study is to evaluate the enhanced signal processing features of the Nucleus 6 Sound Processor on existing Nucleus cochlear implant recipients currently using the Nucleus 5 Sound Processor.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Greater than 12 years
  • Unilateral cochlear implant recipient (CI24RE, CI500, CI422)
  • Minimum of 3 months experience with the N5 sound processor
  • Prior documentation of sentence recognition testing in noise at a difficulty of +10 dB SNR or better
  • Native English speaker
  • Willingness to participate in and comply with all requirements of the protocol
Exclusion Criteria
  • Unrealistic expectations
  • Unwillingness to comply with investigational requirements of the protocol
  • Additional handicaps that would prevent or restrict participation in the evaluations

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
N6 Input Processing FeaturesNucleus 6 Sound Processor-
Primary Outcome Measures
NameTimeMethod
Endpoint 1: Evaluation of Signal to Noise Ratio - Noise ReductionVisit 2, 1 month after baseline testing

Speech understanding in noise using AzBio sentences with and without the SNR - noise reduction algorithm enabled. Speech understanding at a fixed +10 dB signal to noise level in each condition (on/off) is scored as percent correct and then subtracted to demonstrate the percent difference (benefit) in performance of having the algorithm on vs off.

Endpoint 2: Evaluation of SCANVisit 2, 1 month after baseline testing

Speech understanding in noise using AzBio sentences with and without SCAN algorithm enabled. Speech understanding at a fixed +10 dB signal to noise level in each condition (on/off) is scored as percent correct and then subtracted to demonstrate the percent difference (benefit) in performance of having the algorithm on vs off.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Rocky Mountain Ear Center

🇺🇸

Englewood, Colorado, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Center for Hearing and Balance

🇺🇸

Chesterfield, Missouri, United States

Houston Ear Research Foundation

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath